|
Registration benefits include:
|
|
Access to CME/CE programs and certification
|
|
|
Free subscription to Biologic Bulletin newsletter
|
|
|
Reminders of new CME/CE activities
|
 REGISTER NOW
|
|
This Web site is supported by an
unrestricted educational grant from
Genentech, Inc.
|
|
|
|
 |
| |
PsoriasisTx is a free educational Web site designed to provide dermatologists and dermatology nurses with the latest information about biologic therapies used to treat patients with moderate to severe psoriasis.
CLOSING THE GAP
|
When you encounter a patient who has not achieved an
adequate response to a biologic agent, what do you do?
|
|
WHAT'S NEW
NEW! - Clinically Challenging Cases - Expert Insights
CME SPOTLIGHT
|
|
The Impact of Weight on Long-Term Success in Psoriasis Treatment
CME-Certified Internet Enduring Activity
Archive of a CME Web teleconference series held June–August 2007
Release Date: October 2007
It is important for dermatologists to learn about the comorbidities commonly found in psoriasis patients who are obese, as well as the other weight-related factors that may affect the treatment outcome of psoriasis patients who receive biologic therapy. This CME activity explores the data on obesity and psoriasis and will further educate dermatologists on the effect of weight on successful treatment of this patient population.
Co-sponsored by the Dannemiller Memorial Educational Foundation and Curatio CME Institute
Support for this activity has been provided through an educational grant from Genentech, Inc.
Access this activity by clicking on Read More link below.
|
|
READ MORE
|
|
EXPERT PRACTICE HIGHLIGHT
|
 |
Examining Comorbidities Associated With Psoriasis
CME-Certified Expert Practice Article
An interview with J. Mark Jackson, MD
Cardiovascular disease is responsible for a substantial number of deaths in the United States each year. Studies have shown that psoriasis patients have a higher occurrence of cardiovascular disease risk factors than do individuals without psoriasis. In this Expert Practice, J. Mark Jackson, MD, Associate Clinical Professor of Medicine and Dermatology at the University of Louisville School of Medicine, discusses what is currently known about the association of psoriasis and comorbidities related to cardiovascular disease. Topics covered include prevalence of risk factors for cardiovascular disease among psoriasis patients, evaluation of cardiovascular risk factors prior to psoriasis treatment, the impact of psoriasis treatment on cardiovascular risk factors, and similarities in the underlying pathophysiology of psoriasis and cardiovascular risk factors.
|
| READ MORE |
|
MEETING SPOTLIGHT
|
|
Expert Insights on Biologic Agents and Psoriasis: Update From the American Academy of Dermatology (AAD) 66th Annual Meeting
CME-Certified Meeting Report
Edited by: Kenneth B. Gordon, MD
The American Academy of Dermatology held its 66th Annual Meeting February 1–5, 2008 in San Antonio, Texas. A variety of posters that focused on biologic agents used to treat psoriasis were presented, covering such topics as new agents in development, long-term efficacy, and the use of biologic agents in difficult-to-treat patients. In addition, the meeting featured presentations on other topics relating to psoriasis, such as quality-of-life issues, pathophysiology, and comorbidities. This article features highlights from posters presented at the meeting along with insights by Dr. Kenneth B. Gordon on the clinical implications of these studies.
|
| READ MORE |
|
|
|
|
|
